Raymond James Financial’s Enovis ENOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.23M Sell
155,809
-42,507
-21% -$1M ﹤0.01% 3106
2026
Q1
$4.51M Buy
198,316
+47,757
+32% +$1.13M ﹤0.01% 2680
2025
Q4
$4.01M Sell
150,559
-40,224
-21% -$1.19M ﹤0.01% 2684
2025
Q3
$5.79M Sell
190,783
-10,301
-5% -$312K ﹤0.01% 2357
2025
Q2
$6.31M Sell
201,084
-85,500
-30% -$2.83M ﹤0.01% 2214
2025
Q1
$11M Sell
286,584
-87,327
-23% -$3.71M ﹤0.01% 1739
2024
Q4
$16.4M Buy
+373,911
New +$16.4M 0.01% 1466

Other funds holding ENOV

Raymond James Financial's ENOV Position: Q2 2026 in Review

Raymond James Financial reduced its Enovis (ENOV) stake by 21% in Q2 2026, selling an estimated $1M and leaving 155,809 shares worth $3.23M. The position accounts for ﹤0.01% of the portfolio, ranked #3106.

Raymond James Financial first reported a position in ENOV in Q4 2024 and has held it in 7 quarters since. The position peaked at $16.4M in Q4 2024. 253 funds tracked by Wall St. Rank hold ENOV as of Q2 2026.

  • Raymond James Financial held 155,809 shares of Enovis worth $3.23M as of Q2 2026.
  • Raymond James Financial sold 42,507 Enovis shares in Q2 2026, an estimated $1M.
  • Enovis made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3106 holding.
  • Raymond James Financial first reported a position in Enovis in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Enovis position peaked at $16.4M in Q4 2024.
  • 253 funds tracked by Wall St. Rank held Enovis as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.